Search research articles
Contact Us
Filters
Showing results (71-80 of 231) with videos related to
Page
of 24
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 6, 2019
Circulating Interferon-α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et al
Isabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Pediatric Rheumatology Online Journal
|
April 4, 2018
Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre
Maxime Goirand, Sylvain Breton, Frédéric Chevallier, et al.
RMD Open
|
June 15, 2023
Assessment of type I interferon response in routine practice in France in 2022
Anais Nombel, Anne Perrine Foray, Lorna Garnier, et al.
EJNMMI Research
|
April 2, 2024
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus
Sebastian Rodrigo, Stefania Costi, Pierre Ellul, et al.
Journal of Pediatric Hematology/Oncology
|
August 13, 2005
Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French children
Brigitte Bader-Meunier, Guy Leverger, Gil Tchernia, et al.
American Journal of Medical Genetics. Part A
|
June 9, 2012
Progressive polyepiphyseal dysplasia with arthropathy: a distinct disorder from idiopathic juvenile arthritis and pseudorheumatoid dysplasia?
Bertrand Isidor, Sylvaine Poignant, Georges Picherot, et al.
The Journal of Rheumatology
|
June 17, 2011
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry
Brigitte Bader-Meunier, Hélène Decaluwe, Christine Barnerias, et al.
Blood
|
December 16, 2004
Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity
Jérôme Feldmann, Gaël Ménasché, Isabelle Callebaut, et al.
Haematologica
|
December 9, 2008
Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia
Brigitte Bader-Meunier, Suzanne Verlhac, Monique Elmaleh-Bergès, et al.
Rheumatology (Oxford, England)
|
February 24, 2022
Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study
Imène Dabbak, Mathieu P Rodero, Florence A Aeschlimann, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 231) with videos related to
Sort By:
Page
of 24
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 6, 2019
Circulating Interferon-α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et al
Isabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Pediatric Rheumatology Online Journal
|
April 4, 2018
Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre
Maxime Goirand, Sylvain Breton, Frédéric Chevallier, et al.
RMD Open
|
June 15, 2023
Assessment of type I interferon response in routine practice in France in 2022
Anais Nombel, Anne Perrine Foray, Lorna Garnier, et al.
EJNMMI Research
|
April 2, 2024
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus
Sebastian Rodrigo, Stefania Costi, Pierre Ellul, et al.
Journal of Pediatric Hematology/Oncology
|
August 13, 2005
Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French children
Brigitte Bader-Meunier, Guy Leverger, Gil Tchernia, et al.
American Journal of Medical Genetics. Part A
|
June 9, 2012
Progressive polyepiphyseal dysplasia with arthropathy: a distinct disorder from idiopathic juvenile arthritis and pseudorheumatoid dysplasia?
Bertrand Isidor, Sylvaine Poignant, Georges Picherot, et al.
The Journal of Rheumatology
|
June 17, 2011
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry
Brigitte Bader-Meunier, Hélène Decaluwe, Christine Barnerias, et al.
Blood
|
December 16, 2004
Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity
Jérôme Feldmann, Gaël Ménasché, Isabelle Callebaut, et al.
Haematologica
|
December 9, 2008
Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia
Brigitte Bader-Meunier, Suzanne Verlhac, Monique Elmaleh-Bergès, et al.
Rheumatology (Oxford, England)
|
February 24, 2022
Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study
Imène Dabbak, Mathieu P Rodero, Florence A Aeschlimann, et al.
Page
of 24